K041812 is an FDA 510(k) clearance for the MODIFICATION TO ROCHE DIAGNOSTICS PRECINORM PROTEINS IN URINE/CSF (PUC) AND PRECIPATH PROTEINS IN URINE/CSF (PUC). This device is classified as a Multi-analyte Controls, All Kinds (assayed) (Class I - General Controls, product code JJY).
Submitted by Roche Diagnostics Corp. (Indianapolis, US). The FDA issued a Cleared decision on July 27, 2004, 21 days after receiving the submission on July 6, 2004.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1660.